World Rheumatoid Arthritis Market May Reach USD 23.4 Billion in 2016, Says FirstWord
22 Nov 2012 • by Natalie Aster
The global Rheumatoid Arthritis (RA) market is anticipated to grow from $16.5 billion in 2011 to $23.4 billion in 2016. Market expansion will be driven by continued use of existing RA products and the introduction of less invasive pipeline therapies.
“Therapy Trends: Rheumatoid Arthritis -- KOL Insight and Consensus Outlook Modules” report by FirstWord comes in two modules.
Therapy Trends: Rheumatoid Arthritis -- KOL Insight and Consensus Outlook Modules
Published: August, 2012
Price: US$ 7.495,00
KOL Insight provides concise, qualitative KOL analysis of the current and predicted treatment trends, clinical products, and commercial changes in the global sector provided by 8-12 of the field’s foremost key opinion leaders.
Consensus Outlook provides an in-depth 5-year report of the predicted quantitative changes in key market forecast parameters. This module offers access to various charts including market size, product sales, market share by company, competitive status, and detailed market forecasts.
KOL Insight: Rheumatoid Arthritis will help to:
- Identify key factors driving RA drugs
- Understand how biologics are affecting the market
- Determine the unmet clinical needs to RA physicians and patients
Consensus Outlook: Rheumatoid Arthritis will help to:
- Understand RA sales forecast and predicted market growth
- Map your market parameters and chart commercial prospects
- Assess RA market share by company and product
More information can be found in the report “Therapy Trends: Rheumatoid Arthritis -- KOL Insight and Consensus Outlook Modules” by FirstWord.
To order the report or ask for sample pages contact [email protected]